| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |